tiprankstipranks
Chinook Therapeutics (DE:290A)
FRANKFURT:290A

Chinook Therapeutics (290A) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Chinook Therapeutics’s (290A) Moving Averages Convergence Divergence (MACD) indicator is 0.77, suggesting Chinook Therapeutics is a Buy.
Chinook Therapeutics’s (290A) 20-Day exponential moving average is 35.80, while Chinook Therapeutics’s (290A) share price is €36.4, making it a Buy.
Chinook Therapeutics’s (290A) 50-Day exponential moving average is 33.29, while Chinook Therapeutics’s (290A) share price is €36.4, making it a Buy.

Chinook Therapeutics (290A) Pivot Points

May 03, 2024, 07:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
36.13
36.27
36.33
36.47
36.53
36.67
36.73
Fibonacci
36.27
36.34
36.39
36.47
36.54
36.59
36.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Chinook Therapeutics (290A) Moving Averages

May 03, 2024, 07:27 AM
Period
Simple
Exponential
MA5
36.44Sell
36.40Buy
MA10
36.44Sell
36.25Buy
MA20
35.72Buy
35.80Buy
MA50
34.52Buy
33.29Buy
MA100
27.25Buy
29.70Buy
MA200
24.70Buy
26.56Buy
Chinook Therapeutics’s (290A) 10-Day exponential moving average is 36.25, while Chinook Therapeutics’s (290A) share price is €36.4, making it a Buy.
Chinook Therapeutics’s (290A) 100-Day exponential moving average is 29.70, while Chinook Therapeutics’s (290A) share price is €36.4, making it a Buy.
Chinook Therapeutics’s (290A) stock price is €36.4 and Chinook Therapeutics’s (290A) 50-day simple moving average is 34.52, creating a Buy signal.
Chinook Therapeutics’s (290A) stock price is €36.4 and Chinook Therapeutics’s (290A) 100-day simple moving average is 27.25, creating a Buy signal.
Chinook Therapeutics’s (290A) stock price is €36.4 and Chinook Therapeutics’s (290A) 200-day simple moving average is 24.70, creating a Buy signal.

Chinook Therapeutics (290A) Technical Indicators

May 03, 2024, 07:27 AM
Name
Value
Implied Action
RSI (14)
67.20
Neutral
STOCH (9,6)
88.89
Sell
STOCHRSI (14)
88.89
Sell
MACD (12,26)
0.77
Buy
ADX (14)
31.33
Neutral
Williams %R
-11.11
Sell
CCI (14)
70.44
Neutral
ATR (14)
0.40
-
Ultimate Oscillator
66.21
Neutral
ROC
4.00
Buy
Chinook Therapeutics’s (290A) Relative Strength Index (RSI) is 67.20, creating a Neutral signal.
Chinook Therapeutics’s (290A) Trend Strength Indicator (ADX) is 31.33, creating a Neutral signal.
Chinook Therapeutics’s (290A) Commodity Channel Index (CCI) is 70.44, creating a Neutral signal.
Chinook Therapeutics’s (290A) Price Rate of Change (ROC) is 4.00, creating a Buy signal.

FAQ

Is 290A a Buy, Hold, or Sell?
Based on 290A’s technical indicators, 290A is a Buy.
    What is 290A’s RSI (14)?
    290A’s RSI (14) is 67.20, which suggests 290A is a Neutral.
      What is 290A’s MACD?
      290A’s MACD is 0.77, which suggests 290A is a Buy.
        What is 290A’s 5-day moving average?
        290A’s 5-day moving average is 36.44, which suggests 290A is a Sell.
          What is 290A’s 20-day moving average?
          290A 20-day moving average is 35.72, which suggests 290A is a Buy.
            What is 290A’s 50-day moving average?
            290A’s 50-day moving average is 34.52, which suggests 290A is a Buy.
              What is 290A’s 200-day moving average?
              290A’s 200-day moving average is 24.70, which suggests 290A is a Buy.
                What is 290A’s Williams % R (14)?
                290A’s Williams % R (14) is -11.11, which suggests 290A is a Sell.
                  What is 290A’s CCI (14)?
                  290A’s CCI (14) is 70.44, which suggests 290A is a Neutral.
                    What is the share price of Chinook Therapeutics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis